Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells

por Bar, Isabelle, Merhi, Ahmad, Larbanoix, Lionel, Constant, Manuel, Haussy, Sandy, Laurent, Sophie, Canon, Jean-Luc, Delrée, Paul
Publicado 2018

Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first...

por Peeters, Marc, Price, Timothy, Taieb, Julien, Geissler, Michael, Rivera, Fernando, Canon, Jean-Luc, Pentheroudakis, George, Koukakis, Reija, Burdon, Peter, Siena, Salvatore
Publicado 2018

Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with...

por Rivera, Fernando, Karthaus, Meinolf, Hecht, J. Randolph, Sevilla, Isabel, Forget, Frédéric, Fasola, Gianpiero, Canon, Jean-Luc, Guan, Xuesong, Demonty, Gaston, Schwartzberg, Lee S.
Publicado 2017

Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trial

por Siena, Salvatore, Tabernero, Josep, Bodoky, Gyorgy, Cunningham, David, Rivera, Fernando, Ruff, Paul, Canon, Jean Luc, Koukakis, Reija, Demonty, Gaston, Hechmati, Guy, Douillard, Jean-Yves
Publicado 2016

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

por Jézéquel, Pascal, Kerdraon, Olivier, Hondermarck, Hubert, Guérin-Charbonnel, Catherine, Lasla, Hamza, Gouraud, Wilfried, Canon, Jean-Luc, Gombos, Andrea, Dalenc, Florence, Delaloge, Suzette, Lemonnier, Jérôme, Loussouarn, Delphine, Verrièle, Véronique, Campone, Mario
Publicado 2019

Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer

por Toffoli, Sébastien, Bar, Isabelle, Abdel-Sater, Fadi, Delrée, Paul, Hilbert, Pascale, Cavallin, Frédéric, Moreau, Fabrice, Van Criekinge, Wim, Lacroix-Triki, Magali, Campone, Mario, Martin, Anne-Laure, Roché, Henri, Machiels, Jean-Pascal, Carrasco, Javier, Canon, Jean-Luc
Publicado 2014

Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in...

por Berger, Frédérique, Marce, Margaux, Delaloge, Suzette, Hardy-Bessard, Anne-Claire, Bachelot, Thomas, Bièche, Ivan, Pradines, Anne, De La Motte Rouge, Thibault, Canon, Jean-Luc, André, Fabrice, Arnould, Laurent, Clatot, Florian, Lemonnier, Jérôme, Marques, Sandrine, Bidard, François-Clement
Publicado 2022

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasi...

por De Grève, Jacques, Van Meerbeeck, Jan, Vansteenkiste, Johan F., Decoster, Lore, Meert, Anne-Pascale, Vuylsteke, Peter, Focan, Christian, Canon, Jean-Luc, Humblet, Yves, Berchem, Guy, Colinet, Benoit, Galdermans, Danny, Bosquée, Lionel, Vermeij, Joanna, Dewaele, Alex, Geers, Caroline, Schallier, Denis, Teugels, Erik
Publicado 2016

Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies

por Springuel, Lorraine, Lonez, Caroline, Alexandre, Bertrand, Van Cutsem, Eric, Machiels, Jean-Pascal H., Van Den Eynde, Marc, Prenen, Hans, Hendlisz, Alain, Shaza, Leila, Carrasco, Javier, Canon, Jean-Luc, Opyrchal, Mateusz, Odunsi, Kunle, Rottey, Sylvie, Gilham, David E., Flament, Anne, Lehmann, Frédéric F.
Publicado 2019

Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families

por Van Marcke, Cédric, Helaers, Raphaël, De Leener, Anne, Merhi, Ahmad, Schoonjans, Céline A., Ambroise, Jérôme, Galant, Christine, Delrée, Paul, Rothé, Françoise, Bar, Isabelle, Khoury, Elsa, Brouillard, Pascal, Canon, Jean-Luc, Vuylsteke, Peter, Machiels, Jean-Pascal, Berlière, Martine, Limaye, Nisha, Vikkula, Miikka, Duhoux, François P.
Publicado 2020

A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer

por Schuler, Martin, Awada, Ahmad, Harter, Philipp, Canon, Jean Luc, Possinger, Kurt, Schmidt, Marcus, De Grève, Jacques, Neven, Patrick, Dirix, Luc, Jonat, Walter, Beckmann, Matthias W., Schütte, Jochen, Fasching, Peter A., Gottschalk, Nina, Besse-Hammer, Tatiana, Fleischer, Frank, Wind, Sven, Uttenreuther-Fischer, Martina, Piccart, Martine, Harbeck, Nadia
Publicado 2012

Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer

por Metzger-Filho, Otto, Catteau, Aurélie, Michiels, Stefan, Buyse, Marc, Ignatiadis, Michail, Saini, Kamal S., de Azambuja, Evandro, Fasolo, Virginie, Naji, Sihem, Canon, Jean Luc, Delrée, Paul, Coibion, Michel, Cusumano, Pino, Jossa, Veronique, Kains, Jean Pierre, Larsimont, Denis, Richard, Vincent, Faverly, Daniel, Cornez, Nathalie, Vuylsteke, Peter, Vanderschueren, Brigitte, Peyro-Saint-Paul, Hélène, Piccart, Martine, Sotiriou, Christos
Publicado 2013

Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomize...

por Buisseret, Laurence, Loirat, Delphine, Aftimos, Philippe, Maurer, Christian, Punie, Kevin, Debien, Véronique, Kristanto, Paulus, Eiger, Daniel, Goncalves, Anthony, Ghiringhelli, François, Taylor, Donatienne, Clatot, Florent, Van den Mooter, Tom, Ferrero, Jean-Marc, Bonnefoi, Hervé, Canon, Jean-Luc, Duhoux, Francois P., Mansi, Laura, Poncin, Renaud, Barthélémy, Philippe, Isambert, Nicolas, Denis, Zoë, Catteau, Xavier, Salgado, Roberto, Agostinetto, Elisa, de Azambuja, Evandro, Rothé, Françoise, Craciun, Ligia, Venet, David, Romano, Emanuela, Stagg, John, Paesmans, Marianne, Larsimont, Denis, Sotiriou, Christos, Ignatiadis, Michail, Piccart-Gebhart, Martine
Publicado 2023